Thursday, May 12, 2011
In the last seven months, Agilent Technologies Inc. has
entered into two major partnerships with newly formed academic institutes
focused on synthetic biology. The company thinks synthetic biology is
strategically important because it encompasses all three of Agilent's core
business areas: electronic measurements, chemical analysis and life sciences.
The collaborations give the company an opportunity to get in on the ground
floor of an emerging field that is in need of faster and more precise
Cain, C. SciBX 4(19); doi:10.1038/scibx.2011.533 Published
online May 12, 2011
Agilent Technologies Inc.
(NYSE:A), Santa Clara, Calif.
Institute of MIT and Harvard,
Hospital Boston, Boston, Mass.
Medical School, Boston, Mass.
National Laboratory, Berkeley, Calif.
Synthetic Biology Institute at the University of
California, Berkeley, Calif.
for Biologically Inspired Engineering at Harvard University,